© British Blood Transfusion Society
Edited By: Dr David Roberts
Impact Factor: 1.14
ISI Journal Citation Reports © Ranking: 2011: 63/68 (Hematology)
Online ISSN: 1365-3148
The editorial policy of Transfusion Medicine reflects the interests of clinicians, scientists and other professionals working in the field of transfusion medicine. Authors wishing to submit a paper for publication in Transfusion Medicine are asked to follow the guidelines below. Submission of manuscripts
All manuscripts should be submitted online via ScholarOne (formerly known as Manuscript Central) - http://mc.manuscriptcentral.com/transmed .
Full instructions and support are available on the site and a user ID and password can be obtained on the first visit. If you cannot submit online please contact the Editorial Office (firstname.lastname@example.org)
If you have any queries regarding manuscript submission, please contact Maria Davie in the Editorial Office by email (email@example.com)
Each article should be accompanied by a covering letter, signed by the main author, which states the following: 'The manuscript has been seen and approved by all authors, it is not under active consideration for publication, has not been accepted for publication, nor has it been published, in full or in part (except in abstract form)'. It should be noted that review of articles cannot proceed until the signed statement is received.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the ELF
If the OnlineOpen option is not selected the corresponding author will be presented with the ELF to sign. The terms and conditions of the ELF can be previewed below:
Note to Contributors on Deposit of Accepted Version
Certain funders, including the NIH, members of the Research Councils UK (RCUK) and Wellcome Trust require deposit of the Accepted Version in a repository after an embargo period. Details of funding arrangements are set out at the following website:
http://www.wiley.com/go/funderstatement. Please contact the Journal production editor if you have additional funding requirements.
Wiley has arrangements with certain academic institutions to permit the deposit of the Accepted Version in the institutional repository after an embargo period. Details of such arrangements are set out at the following website: http://www.wiley.com/go/funderstatement
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.aspand visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:
Creative Commons Attribution License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html
Articles will normally be reviewed by two expert referees and the Editor's decision is final. The Editor will acknowledge the assistance of the referees at the end of each volume of the journal.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://olabout.wiley.com/WileyCDA/Section/id-406241.html.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://authorservices.wiley.com/bauthor/onlineopen_order.asp. Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
PRE-ACCEPTANCE ENGLISH-LANGUAGE EDITING SERVICES
Transfusion Medicine is pleased to recommend to authors pre-acceptance English-language editing services. Details can be found at http://authorservices.wiley.com/bauthor/english_language.asp The Editor may recommend an English-language editing service to the author as a condition of acceptance. In these circumstances, the journal will offer to contribute toward the cost of using the service.
Authors should keep a copy of their manuscript for reference.
Manuscripts should be submitted online via ScholarOne (formerly known as Manuscript Central) - http://mc.manuscriptcentral.com/transmed
The first page should bear the title of the paper (which should be brief) and name of the author(s), together with the name of the hospital, laboratory or institution. It should also include the name, email address and full postal address of the author for correspondence and offprint requests; this will appear as a footnote in the journal and the publishers will send the proofs to this author at the given address unless contrary instructions are written on the manuscript. A running title of no more than 50 characters (including spaces) should be included.
All pages should be numbered consecutively.
The body of the paper should normally be divided into Introduction, Materials and Methods, Subjects Studied, Results, Discussion, Acknowledgements and References. SI units should be used throughout and authors should refer to Units, Symbols and Abbreviations published by the Royal Society of Medicine. Units should be expressed in the following way: mg mL-1. Numbers are written in full to nine, numerals are used from 10 upwards. Abbreviations must be written in full at the beginning of a sentence. The 24-hour clock is used. Statistical methods should be defined and any not in common use should be described in detail or supported by references. The Editor reserves the right to make literary changes.
WHEN SUBMITTING YOUR MANUSCRIPT, PLEASE ENSURE THAT YOU REFER TO GUIDELINES BELOW WHICH EXPLAIN THE STRUCTURE THAT THE VARIOUS TYPES OF MANUSCRIPT MUST TAKE.
PLEASE NOTE THAT THE EDITOR MAY NOT CONSIDER YOUR MANUSCRIPT FOR PUBLICATION IN TRANSFUSION MEDICINE IF THESE GUIDELINES ARE NOT MET.
Should contain a structured abstract of no more than 250 words rather than a summary with the following headings: Objectives; Background; Methods/Materials; Results; Conclusion.
- They should be no longer than 5000 words and contain not more than 60 references and no more than six figures/tables.
Should contain a structured abstract of no more than 200 words rather than a summary with the following headings: Objectives; Background; Methods/Materials; Results; Conclusion.
- They should be no longer than 3000 words and contain no more than 25 references and no more than three tables/figures.
Review Articles should be no more than 6000 words and contain no more than 60 references and no more than six figures/tables.
These may include case reports, do not require abstracts, should be no more than 1200 words and must contain no more than one figure or table and no more than ten references.
Hospital and Clinical Practice
This new section includes papers which look at the blood transfusion process and clinical transfusion issues and are not always so amenable to statistical and scientific rigour. Papers should be no more than 3000 words and no more than 25 references.
Sub-headings should be used to guide the reader. The relative importance of headings must be clearly indicated.
These should be referred to in the text as figures using Arabic numbers, e.g. Fig. 1, Fig. 2, etc., in order of appearance. Tables and figures should not appear within the main body of the text but on a separate page and identified appropriately. Each figure should have a legend clearly describing it; these legends should be grouped on a separate page at the end of the manuscript. These should not be larger than A4 and may be in the form of digital files.
Images should be suitable for online viewing. Digital files in accordance with our instructions at http://authorservices.wiley.com/prep_illust.asp can be used by production. EPS (illustrations, graphs, annotated artwork; minimum resolution 800 dpi) and TIFF (micrographs, photographs; minimum resolutions 300 dpi) are recommended, although in some cases other formats can be used. Files should be at print size.
It is the policy of Transfusion Medicine for authors to pay the full cost for the reproduction of their colour artwork. Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Blackwell Publishing requires you to complete and return a colour work agreement before your paper can be published. This form can be downloaded as a PDF from the internet. The web address for the form is: http://www.blackwellpublishing.com/pdf/SN_Sub2000_X_CoW.pdf
A soft and hard copy of the Colour Work Agreement Form (CWA) must be sent to the following address:
Wiley-Blackwell, Journal Content Management
John Wiley & Sons Singapore
1 Fusionopolis Walk,
#07-01 Solaris South Tower,
Fax: 65 6643 8598 or 65 6643 8599
Any article received by Wiley-Blackwell with colour work will not be published until the form has been returned.
We would like to receive your artwork in electronic form. Please save vector graphics (e.g. line artwork) in Encapsulated Postscript Format (EPS), and bitmap files (e.g. half-tones) in Tagged Image File Format (TIFF). Ideally, vector graphics that have been saved in metafile (.WMF) or pict (.PCT) format should be embedded within the body of the text file. Detailed information on our digital illustration standards can be found at http://authorservices.wiley.com/bauthor/illustration.asp
These should include only essential data. Each table must be typewritten on a separate sheet and should be numbered consecutively in Arabic numerals, e.g. Table 1, and given a short caption.
Only papers closely related to the work presented should be referred to; exhaustive lists should be avoided. In the text references should give the author's surname with the year of publication in parentheses. If more than one reference is cited, they should be in chronological order. Where the reference contains more than two authors, it should be given at each mention in the text with only the first surname plus et al., e.g. (Smith et al. 1989). If citing several papers by the same author(s) and from the same year, add a, b, c, etc., after the year of publication, e.g. (Smith et al. 1989 a,b). When more than one reference is made in the text to a book or monograph, referring to different pages, etc., each textual reference should contain the author's surname, the year of publication and the appropriate page number; the complete reference is thus cited only at the end of the paper. All references should be brought together at the end of the paper in alphabetical order, with names of all authors, titles of journals given in full and with both first and last page numbers given. Examples:
Coombs, R.R.A., Mourant, A.E. & Race, R. (1945) A new test for the detection of weak and 'incomplete' Rh agglutinins. British Journal of Experimental Pathology, 26, 255-266.
Bowman, J.M., Pollock, J.M. & Biggins, K.R. (1988) Antenatal studies and the management of haemolyticdisease of the newborn. In: Blood Transfusion, Methods in Haematology (ed. Greenwalt, T.J.),17, 163-212. Churchill Livingstone, Edinburgh.
Perry, R.M. (1983) The occurrence and significance of platelet and granulocyte specific antibodies in bone marrow transplantation. PhD thesis, University of London.
Unpublished material should be referenced in the text only with the authors name and initials.
Authors are responsible for the accuracy of references: they must check every reference in the manuscript and again in the proofs.
All authors must fulfil the following three criteria:
• Substantial contributions to research design, or the acquisition, analysis or interpretation of data,
• Drafting the paper or revising it critically, and
• Approval of the submitted and final versions.
In the Acknowledgments section of the paper all authors, must indicate their specific contributions to the work described in the manuscript. Some examples include
• X performed the research
• Y designed the research study
• Z contributed essential reagents or tools
• A analysed the data
• B wrote the paper.
An author may list more than one contribution, and more than one author may have contributed to the same element of the work. E.g. ‘A performed the research, A and C analysed the data and wrote the paper, E contributed the knockout mice for the study and G designed the research study and wrote the paper’.
ETHICAL POLICY AND GUIDELINES
The journal to which you are submitting your manuscript employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
Read the Editorial on plagiarism by Professor David Roberts here.
The Journal’s ethical policies are outlined in the separate document Ethical Policies of Transfusion Medicine. Submitted work must comply with this policy, which is based on the Committee on Publication Ethics (COPE) guidelines on good publication and comply with their Code of Conduct.
Transfusion Medicine will not consider papers that have been accepted for publication or published elsewhere. Copies of existing manuscripts with potentially overlapping or duplicative material should be submitted together with the manuscript, so that the Editors can judge suitability for publication. The Editors reserve the right to reject a paper on ethical grounds.
DISCLOSURE AND COMPETING INTERESTS STATEMENTS
Authors are required to disclose financial interests in any company or institution that might benefit from their publication. A competing interest exists when a primary interest (such as patients’ welfare or the validity of research) might be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors of a Transfusion Medicine article when they have a financial interest that may influence their interpretation of their results or those of others. Financial interests are the easiest to define and they have the greatest potential to influence the objectivity, integrity or perceived value of a publication. They may include any or all, but are not limited to, the following:
• Personal financial interests: Stocks or shares in companies that may gain or lose financially through publication; consultant fees or fees from speakers bureaus other forms of remuneration from organisations that may gain or lose financially; patents or patent applications whose value may be affected by publication.
• Funding: Research support from organisations that might gain or lose financially through publication of the paper.
• Employment: Recent, present or anticipated employment of you or a family member by any organization that may gain or lose financially through publication of the paper. Any such competing interest that authors may have should be declared. The aim of the statement is not to eradicate competing interests, as they are almost inevitable. Papers will not be rejected because there is a competing interest, but a declaration on whether or not there are competing interests will be added to the paper.
• Patent rights
• Consultancy work.
All authors must disclose competing interests, or state “none” via the Journal's ScholarOne Manuscripts website.
All sources of funding must be disclosed in the Acknowledgments section of the paper. List governmental, industrial, charitable, philanthropic and/or personal sources of funding used for the studies described in the manuscript. Attribution of these funding sources is preferred. Examples:
• This work was supported by a grant from the National Institutes of Health, USA (DKxxxx to AB).
• This work was supported by the Crohn's and Colitis Foundation of Canada (grant to AB and CD).
• This work was supported by a grant from Big Pharma Inc. (to AB) and equipment was donated by Small Pharma Inc. EF received a graduate studentship award from the University of xxxxx.
For papers where there are no competing interests, all authors must include the statement ‘Competing interests: the authors have no competing interests.’ We will also ask reviewers to provide a statement of competing interests.
The corresponding author will receive an e-mail alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Excessive changes made by the author in the proofs, excluding typesetting errors, will be charge separately.
AUTHOR SERVICES AND OFFPRINTS
Online production tracking is now available for your article through Wiley-Blackwell's Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don’t need to contact the production editor to check on progress. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Free access to the final PDF offprint of your article will be available via author services only. Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.